Mandatory XML Submission
As part of the regulatory updates, it is important to note that the submission of adverse event reports in the XML (E2B) format will become mandatory for all pharmaceutical companies in Mexico. This shift underscores the need for companies to prepare for compliance with the new requirements.

The implementation of the E-reporting Industria system and the transition to mandatory XML (E2B) submissions represent significant advancements in pharmacovigilance practices across LATAM. By understanding these key aspects and preparing accordingly, pharmaceutical companies can navigate the regulatory landscape effectively and contribute to enhanced drug safety in the region.